Recently filed by Technoderma Medicines Pte Ltd, a groundbreaking patent introduces a small molecule compound designed for hydrogen storage, described in molecular formula.
The compound, denoted by specific structural features, offers notable advancement over existing technologies. This invention represents a significant stride towards more efficient and specific storage solutions in the hydrogen energy sector.
Features and Improvements
The patented compound features a unique molecular structure where X1 and X2 are either carbon or nitrogen atoms. The compound also incorporates a carbocyclic or heterocyclic ring (G1) with aromatic properties. Critically, any hydrogen atoms on the G1 ring can be replaced by a nitrogen-containing group (R1). This detailed structural arrangement enables the compound to function as an effective and specific JAK kinase inhibitor, particularly focusing on Tyk2 and/or JAK1 inhibition, and combinations thereof.
Potential Applications
While traditionally JAK kinase inhibitors have been associated with medical applications, this molecular design’s high efficacy and specificity can be harnessed for hydrogen storage — an application gaining traction in energy science. Hydrogen, a potent clean energy carrier, requires sophisticated storage solutions. The unique configuration of the compound allows for enhanced storage efficiency and safety,
